✦ LIBER ✦

Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial

✍ Scribed by William O. Williford; William F. Krol; Stuart Jon Spechler

Book ID: 113297941
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 669 KB
Volume: 15
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(94)90031-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and validation of a rhinocon

Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials☆☆☆★

✍ Wasserfallen, Jean-Blaise; Gold, Karen; Schulman, Kevin A.; Baraniuk, James N. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 667 KB

M1926 A Prospective Trial to Investigate

M1926 A Prospective Trial to Investigate the Efficacy of Addition of Prokinetics to Proton Pump Inhibitor (PPI) for PPI-Resistant Gastroesophageal Reflux Disease (GERD) Using Symptom and Quality of Life Indexes

✍ Miyamoto, Masaki; Takeuchi, Keisuke; Haruma, Ken 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Development and validation of the Compos

Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents

✍ Wildfire, Jeremy J.; Gergen, Peter J.; Sorkness, Christine A.; Mitchell, Herman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 702 KB

The need for levodopa as an end point of

The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol

✍ Dr. Peter LeWitt; David Oakes; Lu Cui 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

## Abstract Progression of Parkinson's disease (PD) can be detected through changes in clinical ratings or disability assessments. A clinical trial, Deprenyl and Alpha‐Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), used a novel study end point: increase in parkinsonian disability to th

Empirical evidence for using subjective

Empirical evidence for using subjective quality of life as an outcome variable in clinical studies: A meta-analysis of correlates and predictors in persons with a major mental disorder living in the community

✍ Solfrid Vatne; Stål Bjørkly 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 599 KB

Are accelerometers a useful tool for mea

Are accelerometers a useful tool for measuring disease activity in children with eczema? Validity, responsiveness to change, and acceptability of use in a clinical trial setting

✍ C.I. Wootton; K. Koller; S. Lawton; C. O’Leary; K.S. Thomas; on behalf of the SW 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB